ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ICAD Icade

27.30
0.10 (0.37%)
Last Updated: 09:08:13
Delayed by 15 minutes
Share Name Share Symbol Market Type
Icade EU:ICAD Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.10 0.37% 27.30 27.24 27.30 27.30 27.10 27.24 7,507 09:08:13

iCAD Schedules Third Quarter Conference Call for Thursday, October 27, 2005

21/10/2005 6:00pm

PR Newswire (US)


Icade (EU:ICAD)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Icade Charts.
NASHUA, N.H., Oct. 21 /PRNewswire-FirstCall/ -- iCAD(R), Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that W. Scott Parr, President and CEO of iCAD, Inc., will discuss the Company's results for the quarter ended September 30, 2005, during a conference call scheduled for Thursday, October 27, 2005, at 11:00am ET. The Company's financial results for the third quarter are scheduled to be released earlier that day. Shareholders and other interested parties may participate in the conference call by dialing +1 866 713 8307 (domestic) or +1 617 597 5307 (international) and entering passcode 42833782, a few minutes before 11:00am ET on October 27, 2005. The call will also be broadcast live on the Internet at http://www.streetevents.com/, http://www.fulldisclosure.com/ or http://www.icadmed.com/. A replay of the conference call will be accessible two hours after its completion through November 3, 2005 by dialing +1 888 286 8010 (domestic) or +1 617 801 6888 (international) and entering passcode 74745312. The call will also be archived for 90 days at http://www.streetevents.com/, http://www.fulldisclosure.com/ and http://www.icadmed.com/. About iCAD, Inc. iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier by making medical services more effective, more accessible and more affordable for patients worldwide. Recipient of Frost & Sullivan's Growth Strategy Leadership award, iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over eleven hundred women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com/. iCAD is a registered trademark of iCAD, Inc. For iCAD investor relations, contact Kevin McGrath of Cameron Associates at +1 212 245 4577 or via email at . DATASOURCE: iCAD, Inc. CONTACT: Kevin McGrath of Cameron Associates, +1-212-245-4577, Web site: http://www.icadmed.com/ http://www.fulldisclosure.com/ http://www.streetevents.com/

Copyright

1 Year Icade Chart

1 Year Icade Chart

1 Month Icade Chart

1 Month Icade Chart

Your Recent History

Delayed Upgrade Clock